Biotechnology Stocks
240 US-listed companies in the Biotechnology industry, part of the Healthcare sector, ranked by market capitalisation. Open any ticker for quotes, charts, financials and analyst ratings.
Companies
240
Market cap
1.17T
P/E
21.2
Div yield
8.21%
Perf 1M
-0.49%
Perf YTD
26.67%
All 240 Biotechnology stocks
| Ticker | Company | Price | Change | Market cap | P/E | Perf YTD |
|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | 483.33 | -1.44% | 122.67B | 28.7 | 6.61% |
| REGN | Regeneron Pharmaceuticals, Inc. | 695.42 | 0.03% | 71.64B | 16.9 | -9.90% |
| ARGX | argenx SE | 882.56 | 1.18% | 54.88B | 33.6 | 4.95% |
| RVMD | Revolution Medicines, Inc. | 180.92 | -1.60% | 38.46B | — | 127.14% |
| ALNY | Alnylam Pharmaceuticals, Inc. | 286.62 | -0.62% | 38.27B | 68.1 | -27.92% |
| ONC | BeOne Medicines AG | 327.21 | -0.98% | 34.97B | 7.0 | 7.70% |
| INCY | Incyte Corporation | 127.10 | -2.18% | 25.39B | 17.9 | 28.68% |
| ROIV | Roivant Sciences Ltd. | 32.87 | -2.87% | 23.64B | — | 51.47% |
| BNTX | BioNTech SE | 92.95 | 0.54% | 23.51B | — | -2.36% |
| INSM | Insmed Incorporated | 103.12 | -0.97% | 22.35B | — | -40.75% |
| UTHR | United Therapeutics Corporation | 524.70 | 0.20% | 22.27B | 19.4 | 7.69% |
| MRNA | Moderna, Inc. | 54.49 | -2.37% | 21.62B | — | 84.77% |
| NBIX | Neurocrine Biosciences, Inc. | 180.79 | -1.12% | 18.18B | 27.9 | 27.47% |
| GMAB | Genmab A/S | 28.52 | -1.66% | 17.51B | 21.6 | -7.40% |
| BBIO | BridgeBio Pharma, Inc. | 83.54 | -2.35% | 16.36B | — | 9.22% |
| JAZZ | Jazz Pharmaceuticals plc | 255.97 | -0.37% | 16.08B | — | 50.57% |
| ASND | Ascendis Pharma A/S | 252.05 | -0.94% | 15.66B | 28.4 | 18.20% |
| EXEL | Exelixis, Inc. | 55.33 | -2.09% | 13.91B | 18.3 | 26.24% |
| MDGL | Madrigal Pharmaceuticals, Inc. | 546.88 | 1.50% | 12.61B | — | -6.09% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 86.22 | 0.51% | 12.14B | — | 29.87% |
| BMRN | BioMarin Pharmaceutical Inc. | 61.37 | -1.13% | 11.86B | 44.1 | 3.26% |
| AXSM | Axsome Therapeutics, Inc. | 227.42 | -2.90% | 11.70B | — | 24.52% |
| TECH | Bio-Techne Corporation | 72.03 | -0.06% | 11.28B | 104.4 | 22.48% |
| KRYS | Krystal Biotech, Inc. | 363.28 | -0.26% | 10.71B | 48.6 | 47.35% |
| SMMT | Summit Therapeutics Inc. | 12.80 | 1.99% | 9.93B | 142.2 | -26.82% |
| HALO | Halozyme Therapeutics, Inc. | 83.28 | -0.20% | 9.88B | 30.0 | 23.74% |
| CYTK | Cytokinetics, Incorporated | 78.39 | -1.33% | 9.75B | — | 23.37% |
| NUVL | Nuvalent, Inc. | 123.96 | 0.00% | 9.13B | — | 23.23% |
| IONS | Ionis Pharmaceuticals, Inc. | 54.04 | -2.28% | 8.93B | — | -31.69% |
| CRNX | Crinetics Pharmaceuticals, Inc. | 83.88 | 0.02% | 8.88B | — | 80.19% |
| ABVX | Abivax S.A. | 118.84 | -4.34% | 8.73B | — | -11.87% |
| KYMR | Kymera Therapeutics, Inc. | 105.25 | -0.86% | 8.66B | — | 35.27% |
| PTGX | Protagonist Therapeutics, Inc. | 133.00 | -2.81% | 8.55B | — | 52.28% |
| APGE | Apogee Therapeutics, Inc. | 134.20 | 0.02% | 8.30B | — | 77.80% |
| TGTX | TG Therapeutics, Inc. | 53.48 | -2.53% | 8.19B | 18.7 | 79.40% |
| ALKS | Alkermes plc | 48.34 | -4.28% | 8.06B | 53.7 | 72.77% |
| IMVT | Immunovant, Inc. | 38.61 | -0.75% | 7.93B | — | 51.89% |
| PCVX | Vaxcyte, Inc. | 52.98 | -2.97% | 7.65B | — | 14.82% |
| RYTM | Rhythm Pharmaceuticals, Inc. | 106.53 | -1.40% | 7.31B | — | -0.48% |
| IBRX | ImmunityBio, Inc. | 6.83 | -2.01% | 7.15B | — | 244.95% |
| COGT | Cogent Biosciences, Inc. | 39.57 | -2.70% | 6.76B | — | 11.40% |
| CNTA | Centessa Pharmaceuticals plc | 40.50 | 0.00% | 6.27B | — | 61.94% |
| PTCT | PTC Therapeutics, Inc. | 74.49 | -1.19% | 6.18B | — | -1.94% |
| PRAX | Praxis Precision Medicines, Inc. | 291.03 | -1.62% | 6.15B | — | -1.26% |
| ERAS | Erasca, Inc. | 17.72 | -2.42% | 6.15B | — | 376.34% |
| BLTE | Belite Bio, Inc | 152.44 | -2.25% | 6.11B | — | -4.70% |
| CGON | CG Oncology Inc. | 69.12 | -4.82% | 6.10B | — | 66.47% |
| SYRE | Spyre Therapeutics, Inc. | 97.87 | -2.09% | 5.91B | — | 198.75% |
| SRRK | Scholar Rock Holding Corporation | 49.06 | -0.63% | 5.88B | — | 11.37% |
| LGND | Ligand Pharmaceuticals Incorporated | 288.01 | -2.79% | 5.77B | 39.1 | 52.33% |
| MIRM | Mirum Pharmaceuticals, Inc. | 107.57 | -4.15% | 5.40B | — | 36.18% |
| TVTX | Travere Therapeutics, Inc. | 55.56 | -0.63% | 5.17B | — | 45.41% |
| XENE | Xenon Pharmaceuticals Inc. | 63.10 | -2.83% | 4.98B | — | 40.79% |
| DFTX | Definium Therapeutics, Inc. | 42.16 | 0.48% | 4.60B | — | 214.86% |
| CRSP | CRISPR Therapeutics AG | 47.64 | 0.19% | 4.59B | — | -9.15% |
| ACAD | ACADIA Pharmaceuticals Inc. | 26.34 | 1.27% | 4.51B | 12.0 | -1.39% |
| MANE | Veradermics, Incorporated | 107.76 | -3.39% | 4.50B | — | 216.94% |
| CAI | Caris Life Sciences, Inc. | 15.59 | 0.00% | 4.41B | — | -42.22% |
| DNTH | Dianthus Therapeutics, Inc. | 104.09 | 2.44% | 4.35B | — | 152.58% |
| EWTX | Edgewise Therapeutics, Inc. | 39.75 | -1.49% | 4.28B | — | 60.15% |
| DYN | Dyne Therapeutics, Inc. | 25.10 | -3.09% | 4.15B | — | 28.32% |
| CELC | Celcuity Inc. | 83.26 | 0.97% | 4.06B | — | -16.52% |
| VKTX | Viking Therapeutics, Inc. | 33.43 | -1.27% | 3.88B | — | -4.97% |
| CPRX | Catalyst Pharmaceuticals, Inc. | 31.49 | 0.00% | 3.85B | 18.2 | 34.92% |
| DNLI | Denali Therapeutics Inc. | 23.85 | -0.83% | 3.79B | — | 44.46% |
| ELVN | Enliven Therapeutics, Inc. | 52.97 | -1.47% | 3.78B | — | 243.96% |
| ADPT | Adaptive Biotechnologies Corporation | 22.56 | 0.18% | 3.61B | — | 38.92% |
| LEGN | Legend Biotech Corporation | 18.85 | -1.00% | 3.49B | — | -13.29% |
| ARQT | Arcutis Biotherapeutics, Inc. | 27.86 | -1.97% | 3.48B | — | -4.06% |
| TLX | Telix Pharmaceuticals Limited | 10.10 | -0.88% | 3.42B | — | 34.85% |
| IDYA | IDEAYA Biosciences, Inc. | 35.59 | -1.58% | 3.38B | — | 2.95% |
| ORKA | Oruka Therapeutics, Inc. | 88.07 | -2.63% | 3.30B | — | 190.56% |
| NAMS | NewAmsterdam Pharma Company N.V. | 27.91 | -0.25% | 3.26B | — | -20.44% |
| ALMS | Alumis Inc. | 26.38 | -2.40% | 3.26B | — | 170.29% |
| TNGX | Tango Therapeutics, Inc. | 25.85 | -3.00% | 3.22B | — | 191.76% |
| RLAY | Relay Therapeutics, Inc. | 18.37 | 0.44% | 3.22B | — | 117.14% |
| IRON | Disc Medicine, Inc. | 73.67 | -1.31% | 2.81B | — | -7.23% |
| GPCR | Structure Therapeutics Inc. | 47.35 | -1.13% | 2.73B | — | -31.92% |
| QURE | uniQure N.V. | 40.07 | 9.30% | 2.73B | — | 67.45% |
| GRAL | GRAIL Inc. | 63.44 | -1.52% | 2.72B | — | -25.88% |
| BEAM | Beam Therapeutics Inc. | 26.02 | -1.03% | 2.68B | — | -6.13% |
| RCUS | Arcus Biosciences, Inc. | 26.45 | -2.22% | 2.66B | — | 10.99% |
| ATAI | Atai Beckley Inc. | 7.18 | 0.00% | 2.66B | — | 75.55% |
| TRVI | Trevi Therapeutics, Inc. | 18.09 | -1.84% | 2.57B | — | 44.49% |
| TARS | Tarsus Pharmaceuticals, Inc. | 58.52 | -0.73% | 2.52B | — | -28.53% |
| CLDX | Celldex Therapeutics, Inc. | 37.51 | 5.42% | 2.50B | — | 38.11% |
| RARE | Ultragenyx Pharmaceutical Inc. | 25.00 | -3.77% | 2.46B | — | 8.70% |
| VCEL | Vericel Corporation | 46.62 | -0.19% | 2.38B | 111.0 | 29.46% |
| VERA | Vera Therapeutics, Inc. | 32.51 | -2.43% | 2.33B | — | -35.80% |
| NUVB | Nuvation Bio Inc. | 6.59 | -1.49% | 2.29B | — | -26.45% |
| PHVS | Pharvaris N.V. | 32.62 | -3.06% | 2.28B | — | 17.55% |
| ANAB | AnaptysBio, Inc. | 52.14 | 0.06% | 2.25B | — | 61.32% |
| IMNM | Immunome, Inc. | 23.11 | -0.47% | 2.21B | — | 7.59% |
| KLRA | Kailera Therapeutics, Inc. | 16.88 | 0.84% | 2.19B | — | -35.08% |
| MBX | MBX Biosciences, Inc. Common Stock | 63.96 | 6.49% | 2.15B | — | 102.79% |
| KOD | Kodiak Sciences Inc. | 40.01 | -0.69% | 2.12B | — | 43.10% |
| AGIO | Agios Pharmaceuticals, Inc. | 35.01 | -2.72% | 2.08B | — | 28.62% |
| HRMY | Harmony Biosciences Holdings, Inc. | 35.86 | 0.25% | 2.08B | 14.5 | -4.17% |
| ZLAB | Zai Lab Limited | 18.31 | -1.66% | 2.07B | — | 3.80% |
| NRIX | Nurix Therapeutics, Inc. | 23.60 | -2.28% | 2.05B | — | 24.41% |
| SION | Sionna Therapeutics, Inc. | 44.81 | -3.74% | 2.02B | — | 8.92% |
| ADMA | ADMA Biologics, Inc. | 8.71 | -0.91% | 2.02B | 12.8 | -52.25% |
| BCRX | BioCryst Pharmaceuticals, Inc. | 9.53 | -2.16% | 2.00B | — | 22.18% |
| URGN | UroGen Pharma Ltd. | 40.45 | -1.05% | 1.97B | — | 72.72% |
| AUPH | Aurinia Pharmaceuticals Inc. | 15.18 | 1.47% | 1.95B | 7.0 | -4.83% |
| FTRE | Fortrea Holdings Inc. | 20.40 | -1.45% | 1.93B | — | 18.26% |
| GHRS | GH Research PLC | 27.98 | 0.07% | 1.92B | — | 120.31% |
| NBTX | Nanobiotix S.A. | 37.85 | 0.08% | 1.92B | — | 63.71% |
| SLS | SELLAS Life Sciences Group, Inc. | 10.10 | 0.10% | 1.88B | — | 167.90% |
| TYRA | Tyra Biosciences, Inc. | 31.11 | 0.74% | 1.85B | — | 18.33% |
| STOK | Stoke Therapeutics, Inc. | 29.48 | 0.31% | 1.84B | — | -7.12% |
| MESO | Mesoblast Limited | 14.13 | -2.21% | 1.83B | — | -21.67% |
| OCUL | Ocular Therapeutix, Inc. | 8.36 | -1.07% | 1.83B | — | -31.14% |
| LKFT | Lakefront Biotherapeutics N.V. | 27.72 | -1.53% | 1.83B | 3.2 | -15.23% |
| VRDN | Viridian Therapeutics, Inc. | 19.88 | 1.90% | 1.79B | — | -36.12% |
| MLYS | Mineralys Therapeutics, Inc. | 26.35 | -2.23% | 1.75B | — | -27.39% |
| DMRA | Damora Therapeutics, Inc. | 28.33 | -3.71% | 1.74B | — | 23.12% |
| SNDX | Syndax Pharmaceuticals, Inc. | 19.22 | -2.09% | 1.70B | — | -8.52% |
| IMCR | Immunocore Holdings plc | 33.42 | -0.27% | 1.70B | — | -3.72% |
| PVLA | Palvella Therapeutics, Inc. | 142.60 | -0.17% | 1.69B | — | 36.24% |
| GENB | Generate Biomedicines, Inc. | 13.08 | -0.46% | 1.68B | — | -12.80% |
| ABCL | AbCellera Biologics Inc. | 5.39 | 1.89% | 1.65B | — | 57.60% |
| SRPT | Sarepta Therapeutics, Inc. | 15.54 | 0.71% | 1.64B | 25.3 | -27.79% |
| AMLX | Amylyx Pharmaceuticals, Inc. | 19.73 | 0.92% | 1.64B | — | 63.33% |
| PGEN | Precigen, Inc. | 5.45 | -1.45% | 1.64B | — | 30.38% |
| IOVA | Iovance Biotherapeutics, Inc. | 4.56 | -2.98% | 1.63B | — | 67.03% |
| ZYME | Zymeworks Inc. | 22.01 | -2.65% | 1.62B | — | -16.41% |
| TSHA | Taysha Gene Therapies, Inc. | 5.61 | 2.75% | 1.61B | — | 2.00% |
| INVA | Innoviva, Inc. | 21.64 | -0.78% | 1.60B | 3.6 | 8.25% |
| MLTX | MoonLake Immunotherapeutics | 18.38 | -1.76% | 1.52B | — | 39.45% |
| SEPN | Septerna Inc | 33.61 | -1.06% | 1.51B | — | 20.55% |
| MAZE | Maze Therapeutics, Inc. | 27.27 | -2.19% | 1.51B | — | -34.18% |
| RAPP | Rapport Therapeutics, Inc. Common Stock | 40.94 | -2.43% | 1.49B | — | 34.94% |
| TRAX | First Tracks Biotherapeutics Inc | 41.87 | 0.05% | 1.46B | — | 104.14% |
| VIR | Vir Biotechnology, Inc. | 8.64 | -2.37% | 1.46B | — | 43.28% |
| XNCR | Xencor, Inc. | 19.53 | -2.20% | 1.45B | — | 27.56% |
| XERS | Xeris Biopharma Holdings, Inc. | 8.38 | 1.70% | 1.45B | 119.7 | 6.75% |
| KALV | KalVista Pharmaceuticals, Inc. | 27.00 | 0.00% | 1.44B | — | 67.18% |
| BHVN | Biohaven Ltd. | 13.43 | -2.47% | 1.42B | — | 18.95% |
| BCAX | Bicara Therapeutics Inc. Common Stock | 25.89 | -3.68% | 1.42B | — | 53.83% |
| GLUE | Monte Rosa Therapeutics, Inc. | 21.56 | -2.18% | 1.40B | — | 37.50% |
| AVBP | ArriVent BioPharma, Inc. | 30.04 | 0.20% | 1.40B | — | 49.30% |
| ZBIO | Zenas BioPharma, Inc. | 31.09 | -3.72% | 1.39B | — | -14.38% |
| NKTR | Nektar Therapeutics | 70.68 | -0.13% | 1.38B | — | 67.17% |
| RXRX | Recursion Pharmaceuticals, Inc. | 2.97 | -2.62% | 1.33B | — | -27.38% |
| ARDX | Ardelyx, Inc. | 5.00 | -1.77% | 1.24B | — | -14.24% |
| NTLA | Intellia Therapeutics, Inc. | 10.80 | -0.83% | 1.21B | — | 20.13% |
| NVAX | Novavax, Inc. | 7.34 | -0.41% | 1.21B | — | 9.23% |
| IMTX | Immatics N.V. | 8.99 | 2.86% | 1.21B | — | -14.38% |
| AKTS | Aktis Oncology, Inc. | 22.39 | -2.52% | 1.20B | — | -17.07% |
| MNKD | MannKind Corporation | 3.85 | -1.53% | 1.19B | — | -32.10% |
| ABSI | Absci Corporation | 6.90 | -3.23% | 1.17B | — | 97.71% |
| ORIC | ORIC Pharmaceuticals, Inc. | 11.28 | -5.29% | 1.17B | — | 37.90% |
| INBX | Inhibrx Biosciences Inc. | 79.25 | -0.54% | 1.16B | — | 0.32% |
| LBRX | LB Pharmaceuticals Inc Common Stock | 39.00 | 11.62% | 1.12B | — | 75.20% |
| WVE | Wave Life Sciences Ltd. | 5.81 | -1.36% | 1.12B | — | -65.82% |
| CRVS | Corvus Pharmaceuticals, Inc. | 13.04 | -2.03% | 1.10B | — | 69.35% |
| SVRA | Savara Inc. | 5.28 | -0.94% | 1.08B | — | -12.44% |
| MGTX | MeiraGTx Holdings plc | 11.62 | -1.69% | 1.08B | — | 46.16% |
| SPTX | Seaport Therapeutics, Inc. Common Stock | 19.74 | -0.80% | 1.06B | — | -6.00% |
| OPK | OPKO Health, Inc. | 1.37 | -16.97% | 1.03B | — | 8.73% |
| LXRX | Lexicon Pharmaceuticals, Inc. | 2.32 | -0.85% | 1.03B | — | 101.74% |
| EYPT | EyePoint Pharmaceuticals, Inc. | 11.92 | -0.33% | 999.39M | — | -34.76% |
| OLMA | Olema Pharmaceuticals, Inc. | 11.19 | -3.70% | 977.42M | — | -55.24% |
| MRVI | Maravai LifeSciences Holdings, Inc. | 6.59 | -3.94% | 956.18M | — | 102.77% |
| ANRO | Alto Neuroscience, Inc. | 26.72 | -2.55% | 937.71M | — | 50.11% |
| PHAT | Phathom Pharmaceuticals, Inc. | 11.64 | -0.17% | 928.36M | — | -29.84% |
| JANX | Janux Therapeutics, Inc. | 14.96 | -0.27% | 912.33M | — | 8.41% |
| GERN | Geron Corporation | 1.40 | -3.45% | 898.13M | — | 6.06% |
| SANA | Sana Biotechnology, Inc. | 3.17 | -3.65% | 882.18M | — | -22.11% |
| PHAR | Pharming Group N.V. | 12.01 | -6.61% | 848.21M | 66.7 | -32.03% |
| ABUS | Arbutus Biopharma Corp | 4.29 | -2.72% | 847.44M | 5.2 | -10.81% |
| OMER | Omeros Corporation | 11.67 | 3.46% | 844.62M | 7.5 | -32.07% |
| BIOA | BioAge Labs Inc. | 22.19 | 1.23% | 835.45M | — | 67.72% |
| CLYM | Climb Bio, Inc. | 12.11 | -1.46% | 825.71M | — | 202.75% |
| KURA | Kura Oncology, Inc. | 8.93 | -4.08% | 792.76M | — | -14.05% |
| DSGN | Design Therapeutics, Inc. | 12.02 | 1.26% | 750.73M | — | 28.14% |
| SGP | SpyGlass Pharma, Inc. Common Stock | 21.91 | 1.34% | 732.52M | — | -8.71% |
| RIGL | Rigel Pharmaceuticals, Inc. | 39.07 | 1.48% | 722.88M | 2.1 | -8.78% |
| MNPR | Monopar Therapeutics Inc. | 107.43 | -1.52% | 719.68M | — | 64.52% |
| ESPR | Esperion Therapeutics, Inc. | 3.18 | -0.31% | 661.15M | — | -14.05% |
| BBOT | BridgeBio Oncology Therapeutics Inc. | 8.24 | -4.07% | 660.08M | — | -34.19% |
| ANL | Adlai Nortye Ltd. | 12.11 | -4.57% | 642.80M | — | 752.82% |
| ACHV | Achieve Life Sciences, Inc. | 6.18 | 0.00% | 634.43M | — | 24.35% |
| JBIO | Jade Biosciences, Inc. | 19.35 | -1.78% | 631.31M | — | 25.41% |
| MDXG | MiMedx Group, Inc. | 4.23 | -2.98% | 630.04M | 21.1 | -37.52% |
| SLDB | Solid Biosciences Inc. | 8.04 | 0.88% | 626.40M | — | 42.55% |
| OCS | Oculis Holding AG | 10.84 | -1.99% | 619.72M | — | -45.72% |
| ACRS | Aclaris Therapeutics, Inc. | 5.12 | -3.94% | 617.45M | — | 70.10% |
| AGMB | AgomAb Therapeutics N.V. American Depositary Shares | 12.40 | -1.12% | 610.67M | — | -15.65% |
| ANNX | Annexon, Inc. | 4.86 | -2.21% | 581.23M | — | -3.19% |
| SPRY | ARS Pharmaceuticals, Inc. | 5.83 | 2.82% | 578.94M | — | -49.96% |
| ZVRA | Zevra Therapeutics, Inc. | 9.78 | 0.51% | 578.15M | 4.5 | 9.15% |
| CRMD | CorMedix Inc. | 7.19 | -2.18% | 564.07M | 3.4 | -38.18% |
| DRUG | Bright Minds Biosciences Inc. | 71.06 | -1.25% | 551.53M | — | -8.94% |
| PRME | Prime Medicine, Inc. | 3.03 | -1.94% | 547.27M | — | -12.68% |
| ODTX | Odyssey Therapeutics, Inc. | 18.05 | -2.06% | 545.63M | — | -9.75% |
| SLN | Silence Therapeutics plc | 11.55 | 0.00% | 545.55M | — | 89.97% |
| RLMD | Relmada Therapeutics, Inc. | 5.14 | -1.72% | 539.13M | — | 6.42% |
| CTNM | Contineum Therapeutics, Inc. | 14.38 | 1.55% | 537.62M | — | 25.81% |
| TECX | Tectonic Therapeutic, Inc. | 28.43 | -4.60% | 536.45M | — | 36.29% |
| NGNE | Neurogene Inc. | 33.66 | 1.32% | 531.91M | — | 63.40% |
| ARVN | Arvinas, Inc. | 8.22 | 0.24% | 530.36M | — | -30.69% |
| CADL | Candel Therapeutics, Inc. | 9.40 | -2.89% | 516.07M | — | 66.37% |
| GYRE | Gyre Therapeutics, Inc. | 5.64 | -5.84% | 515.44M | — | -20.11% |
| CTMX | CytomX Therapeutics, Inc. | 3.17 | -1.55% | 509.81M | 6.3 | -25.59% |
| XOMA | XOMA Royalty Corp. | 40.17 | 0.00% | 503.77M | 25.6 | 51.07% |
| FDMT | 4D Molecular Therapeutics, Inc. | 9.61 | -2.44% | 502.37M | — | 28.13% |
| DNA | Ginkgo Bioworks Holdings, Inc. | 7.62 | -1.04% | 497.77M | — | -8.30% |
| RGNX | REGENXBIO Inc. | 9.62 | 0.21% | 497.33M | — | -33.19% |
| VALN | Valneva SE | 5.07 | 0.20% | 480.75M | — | -42.52% |
| REPL | Replimune Group, Inc. | 5.41 | 1.12% | 454.14M | — | -44.34% |
| RZLT | Rezolute, Inc. | 4.70 | -4.47% | 452.57M | — | 99.15% |
| AURA | Aura Biosciences, Inc. | 7.01 | -0.57% | 450.04M | — | 28.62% |
| PRTA | Prothena Corporation plc | 8.56 | 0.00% | 448.14M | — | -10.37% |
| IMMX | Immix Biopharma, Inc. | 8.17 | -3.20% | 444.46M | — | 56.21% |
| ALLO | Allogene Therapeutics, Inc. | 1.81 | 9.04% | 441.40M | — | 32.12% |
| CABA | Cabaletta Bio, Inc. | 2.62 | -4.03% | 427.20M | — | 19.63% |
| AAPG | Ascentage Pharma Group International | 18.31 | 0.11% | 425.54M | — | -30.22% |
| PRTC | PureTech Health plc | 17.38 | 4.51% | 423.09M | — | 4.45% |
| CBIO | Crescent Biopharma, Inc. | 14.77 | -10.16% | 407.24M | — | 24.54% |
| OCGN | Ocugen, Inc. | 1.19 | -4.03% | 402.84M | — | -11.85% |
| ASMB | Assembly Biosciences, Inc. | 25.11 | -1.80% | 399.07M | — | -26.17% |
| PBYI | Puma Biotechnology, Inc. | 7.81 | -2.01% | 397.52M | 16.3 | 31.26% |
| AUTL | Autolus Therapeutics plc | 1.46 | 0.69% | 388.57M | — | -26.63% |
| EBS | Emergent BioSolutions Inc. | 7.35 | 0.55% | 379.23M | — | -40.53% |
| XFOR | X4 Pharmaceuticals, Inc. | 4.00 | 1.78% | 377.28M | — | 0.00% |
| AVIR | Atea Pharmaceuticals, Inc. | 4.62 | 2.44% | 369.73M | 3.4 | 29.41% |
| ABEO | Abeona Therapeutics Inc. | 6.23 | 3.49% | 355.08M | 4.7 | 18.22% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | 4.31 | -1.82% | 338.43M | — | -56.60% |
| DBVT | DBV Technologies S.A. | 13.73 | 1.70% | 328.45M | — | -28.38% |
| KROS | Keros Therapeutics, Inc. | 9.97 | -0.99% | 319.02M | 6.5 | -51.03% |
| KYTX | Kyverna Therapeutics, Inc. | 7.07 | -5.61% | 309.61M | — | -24.79% |
| VNDA | Vanda Pharmaceuticals Inc. | 5.05 | -2.13% | 303.68M | — | -42.74% |
| CAPR | Capricor Therapeutics, Inc. | 6.57 | -6.14% | 300.36M | — | -77.23% |
| AMRN | Amarin Corporation plc | 14.16 | 1.51% | 292.87M | — | 1.43% |
| IRD | Opus Genetics, Inc. | 3.47 | 1.76% | 286.50M | — | 72.64% |
| VRXA | Veraxa Biotech Holding AG | 1.97 | -0.51% | 278.57M | — | -85.93% |
| PROK | ProKidney Corp. | 1.54 | 0.00% | 228.18M | — | -31.25% |
| GLSI | Greenwich LifeSciences, Inc. | 12.80 | -4.83% | 187.88M | — | -39.08% |